Solubility and dissolution enhancement strategies: current understanding and recent trends*

Abstract Identification of lead compounds with higher molecular weight and lower aqueous solubility has become increasingly prevalent with the advent of high throughput screening. Poor aqueous solubility of these lipophilic compounds can drastically affect the dissolution rate and subsequently the drug absorbed in the systemic circulation, imposing a significant burden of time and money during drug development process. Various pre-formulation and formulation strategies have been applied in the past that can improve the aqueous solubility of lipophilic compounds by manipulating either the crystal lattice properties or the activity coefficient of a solute in solution or both, if possible. However, despite various strategies available in the armor of formulation scientist, solubility issue still remains an overriding problem in the drug development process. It is perhaps due to the insufficient conceptual understanding of solubility and dissolution phenomenon that hinders the judgment in selecting suitable strategy for improving aqueous solubility and/or dissolution rate. This article, therefore, focuses on (i) revisiting the theoretical and mathematical concepts associated with solubility and dissolution, (ii) their application in making rationale decision for selecting suitable pre-formulation and formulation strategies and (iii) the relevant research performed in this field in past decade.

[1]  Po-Chun Hsu,et al.  A portable fiber-optic Raman analyzer for fast real-time screening and identifying cocrystal formation of drug-coformer via grinding process , 2013 .

[2]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[3]  G. Stephenson,et al.  Physical stability of salts of weak bases in the solid-state. , 2011, Journal of pharmaceutical sciences.

[4]  Kwok Chow,et al.  Engineering of pharmaceutical materials: an industrial perspective. , 2008, Journal of pharmaceutical sciences.

[5]  S. Onoue,et al.  Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability. , 2012, Drug metabolism and pharmacokinetics.

[6]  S. Velaga,et al.  Hansen solubility parameter as a tool to predict cocrystal formation. , 2011, International journal of pharmaceutics.

[7]  P. Reusser Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts , 2001, Expert opinion on investigational drugs.

[8]  Carlos E Figueroa,et al.  Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  M. Meunier,et al.  Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[10]  David R. Weyna,et al.  Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .

[11]  C. C. Seaton,et al.  Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients , 2008 .

[12]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[13]  Shobha N. Bhattachar,et al.  Solubility: it's not just for physical chemists. , 2006, Drug discovery today.

[14]  Tommy Liljefors,et al.  Aqueous solubility study of salts of benzylamine derivatives and p-substituted benzoic acid derivatives using X-ray crystallographic analysis. , 2004, International journal of pharmaceutics.

[15]  Xing Tang,et al.  In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion , 2010, Drug development and industrial pharmacy.

[16]  P. Chaudhari,et al.  Solubility enhancement of hydrophobic drugs using synergistically interacting cyclodextrins and cosolvent , 2007 .

[17]  Ravi M Shanker,et al.  Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement , 2011, Pharmaceutical development and technology.

[18]  Atsuo Ohike,et al.  Establishment of new preparation method for solid dispersion formulation of tacrolimus. , 2003, International journal of pharmaceutics.

[19]  Yihui Deng,et al.  Effect of particle size on solubility , dissolution rate , and oral bioavailability : evaluation using coenzyme Q 10 as naked nanocrystals , 2012 .

[20]  H W Frijlink,et al.  A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Manfred Kansy,et al.  High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.

[22]  K. Srinivasan,et al.  Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  K. G. Desai,et al.  Solubility studies on valdecoxib in the presence of carriers, cosolvents, and surfactants , 2004 .

[24]  M. Brewster,et al.  Solvent systems and their selection in pharmaceutics and biopharmaceutics , 2007 .

[25]  S. Yalkowsky,et al.  Solubility of nonelectrolytes in polar solvents III: Alkyl p-aminobenzoates in polar and mixed solvents. , 1975, Journal of pharmaceutical sciences.

[26]  J. Swarbrick,et al.  Encyclopedia of Pharmaceutical Technology , 2006 .

[27]  Anant Paradkar,et al.  Characterization of curcumin-PVP solid dispersion obtained by spray drying. , 2004, International journal of pharmaceutics.

[28]  Amy D. Fung,et al.  Water-soluble prodrugs of an Aurora kinase inhibitor. , 2009, Bioorganic & medicinal chemistry letters.

[29]  E. Squillante,et al.  Formulation development of Carbamazepine–Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process , 2011 .

[30]  W. Hinrichs,et al.  Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs , 2010, Pharmaceutical Research.

[31]  Kevin S. Eccles,et al.  Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal. , 2012, International journal of pharmaceutics.

[32]  Hassan Almoazen,et al.  Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH , 2005, Pharmaceutical Research.

[33]  Hoo-Kyun Choi,et al.  Improved absorption of meloxicam via salt formation with ethanolamines. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  P. Panchmatia,et al.  The influence of salt formation on electrostatic and compression properties of flurbiprofen salts. , 2013, International journal of pharmaceutics.

[35]  M. Du,et al.  Norfloxacin salts with benzenedicarboxylic acids: charge-assisted hydrogen-bonding recognition and solubility regulation , 2013 .

[36]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[37]  P. L. Gould,et al.  Salt selection for basic drugs , 1986 .

[38]  S. Yalkowsky,et al.  Solubility Improvement of Drugs using N-Methyl Pyrrolidone , 2008, AAPS PharmSciTech.

[39]  Hoo-Kyun Choi,et al.  Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. , 2010, International journal of pharmaceutics.

[40]  A. Shevchenko,et al.  A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior. , 2012, International journal of pharmaceutics.

[41]  Ying Zheng,et al.  Stability of nanosuspensions in drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[42]  N. Rodríguez-Hornedo,et al.  Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine , 2008 .

[43]  Alfred N. Martin Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences , 1969 .

[44]  Eva Roblegg,et al.  Nano-extrusion: a One-Step Process for Manufacturing of Solid Nanoparticle Formulations Directly from the Liquid Phase , 2013, AAPS PharmSciTech.

[45]  Naír Rodríguez-Hornedo,et al.  Solubility Advantage of Pharmaceutical Cocrystals , 2009 .

[46]  C. Galli Experimental determination of the diffusion boundary layer width of micron and submicron particles. , 2006, International journal of pharmaceutics.

[47]  Marcel Jaspars,et al.  Hydrocortisone Nanosuspensions for Ophthalmic Delivery : A Comparative Study between Microfluidic Nanoprecipitation and Wet Milling , 2013 .

[48]  Richard J. Bastin,et al.  Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .

[49]  D. Good,et al.  Cocrystal Eutectic Constants and Prediction of Solubility Behavior , 2010 .

[50]  P Augustijns,et al.  Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. , 2007, International journal of pharmaceutics.

[51]  L. S. Taylor,et al.  Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. , 2013, Carbohydrate polymers.

[52]  Thomas Rades,et al.  Emerging trends in the stabilization of amorphous drugs. , 2013, International journal of pharmaceutics.

[53]  K. Matsuzaki,et al.  Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. , 2010, International journal of pharmaceutics.

[54]  E. Bosch,et al.  Solubility-pH profiles of some acidic, basic and amphoteric drugs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[55]  J. F. Liebman,et al.  ESTIMATING ENTROPIES AND ENTHALPIES OF FUSION OF ORGANIC COMPOUNDS , 1991 .

[56]  Patrick Sandra,et al.  The utility of sulfonate salts in drug development. , 2010, Journal of pharmaceutical sciences.

[57]  Jeanette T. Dunlap,et al.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.

[58]  K. Shing,et al.  Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery , 2008 .

[59]  Dave A. Miller,et al.  KinetiSol: A new processing paradigm for amorphous solid dispersion systems , 2012 .

[60]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[61]  Naír Rodríguez-Hornedo,et al.  Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .

[62]  D. Hofmann,et al.  Lattice energy calculation – A quick tool for screening of cocrystals and estimation of relative solubility. Case of flavonoids , 2013 .

[63]  Yihui Deng,et al.  Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals , 2012, International journal of nanomedicine.

[64]  Hirofumi Takeuchi,et al.  Particle design of poorly water-soluble drug substances using supercritical fluid technologies. , 2008, Advanced drug delivery reviews.

[65]  R. Davey,et al.  Making Co-crystals-The utility of ternary phase diagrams , 2007 .

[66]  Y. Pore,et al.  Improvement in physicochemical properties of ezetimibe using a crystal engineering technique , 2012 .

[67]  K. Mahesh,et al.  A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide , 2014 .

[68]  R. Liu Water-Insoluble Drug Formulation, Second Edition , 2008 .

[69]  Y. Zu,et al.  Preparation and characterization of vitexin powder micronized by a supercritical antisolvent (SAS) process , 2012 .

[70]  C. Mueller Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility. , 2010 .

[71]  R. Liu Water-insoluble drug formulation , 2000 .

[72]  D. Law,et al.  Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. , 2004, Journal of pharmaceutical sciences.

[73]  V. Ranade,et al.  Biotechnology: Pharmaceutical Aspects , 2010 .

[74]  T. Tay,et al.  Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  A. Bansal,et al.  Effect of counterions on the properties of amorphous atorvastatin salts. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  James E. Kipp,et al.  Solubilizing Systems for Parenteral Formulation Development—Small Molecules , 2007 .

[77]  Beatrice Perissutti,et al.  Enhanced Oral Bioavailability of Vinpocetine Through Mechanochemical Salt Formation: Physico-Chemical Characterization and In Vivo Studies , 2011, Pharmaceutical Research.

[78]  Henrique A. Matos,et al.  Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process , 2010 .

[79]  A. Aggarwal,et al.  Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000 , 2011, Drug development and industrial pharmacy.

[80]  Naír Rodríguez-Hornedo,et al.  Dependence of cocrystal formation and thermodynamic stability on moisture sorption by amorphous polymer , 2011 .

[81]  Ram B. Gupta,et al.  Formation of itraconazole/L-malic acid cocrystals by gas antisolvent cocrystallization , 2013 .

[82]  M. S. Ku,et al.  A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept , 2012, Pharmaceutical development and technology.

[83]  Z T Chowhan,et al.  pH-solubility profiles or organic carboxylic acids and their salts. , 1978, Journal of pharmaceutical sciences.

[84]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[85]  C. Clark,et al.  Effect of Cosolvents on Toxaphene Aqueous Solubility , 2006 .

[86]  Alfonso R. Gennaro,et al.  Remington:the science and practice of pharmacy , 1995 .

[87]  Geert Verreck,et al.  Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. , 2004, Journal of pharmaceutical sciences.

[88]  C. Müller,et al.  Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility , 2009, Chemistry & biodiversity.

[89]  Patrick Augustijns,et al.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? , 2009, Journal of pharmaceutical sciences.

[90]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[91]  Longqin Hu Prodrugs: effective solutions for solubility, permeability and targeting challenges. , 2004, IDrugs : the investigational drugs journal.

[92]  Rainer H Müller,et al.  Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[93]  R. Holm,et al.  Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches). , 2013, International journal of pharmaceutics.

[94]  S. Yalkowsky,et al.  Solubility and partitioning I: Solubility of nonelectrolytes in water. , 1980, Journal of pharmaceutical sciences.

[95]  Jun-Shik Choi,et al.  Enhanced bioavailability of piroxicam via salt formation with ethanolamines. , 2005, International journal of pharmaceutics.

[96]  Lynne S. Taylor,et al.  Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution , 2010, Pharmaceutical Research.

[97]  Michael Lee Branham,et al.  Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[98]  George Zografi,et al.  Assessing the performance of amorphous solid dispersions. , 2012, Journal of pharmaceutical sciences.

[99]  N. Rodríguez-Hornedo,et al.  Cocrystals and Salts of Gabapentin: pH Dependent Cocrystal Stability and Solubility , 2009 .

[100]  S. Onoue,et al.  Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. , 2010, International journal of pharmaceutics.

[101]  Raviraj M. Kulkarni,et al.  Nanosuspensions: a promising drug delivery strategy , 2004, The Journal of pharmacy and pharmacology.

[102]  R. Bogner,et al.  Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. , 2012, Journal of pharmaceutical sciences.

[103]  Abu T M Serajuddin,et al.  Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. , 2005, Journal of pharmaceutical sciences.

[104]  I. Kellaway,et al.  Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. , 2006, International journal of pharmaceutics.

[105]  K. Amighi,et al.  Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[106]  T. Kojima,et al.  Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties. , 2011, International journal of pharmaceutics.

[107]  W. Acree,et al.  Solubility of Pioglitazone Hydrochloride in Aqueous Solutions of Ethanol, Propylene Glycol, and N-Methyl-2-Pyrrolidone at 298.2°K , 2009, AAPS PharmSciTech.

[108]  B. Perissutti,et al.  Drug salt formation via mechanochemistry: the case study of vincamine. , 2013, Molecular pharmaceutics.

[109]  Lynne S Taylor,et al.  Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[110]  James W McGinity,et al.  Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. , 2010, Journal of pharmaceutical sciences.

[111]  Shobha Bhattachar,et al.  The road map to oral bioavailability: an industrial perspective , 2006, Expert opinion on drug metabolism & toxicology.

[112]  Elies Molins,et al.  Effect of the Counterion on the Solubility of Isostructural Pharmaceutical Lamotrigine Salts , 2009 .

[113]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[114]  Yoshiki Hayashi,et al.  Dissolution Improvement and the Mechanism of the Improvement from Cocrystallization of Poorly Water-soluble Compounds , 2008, Pharmaceutical Research.

[115]  A. Klamt,et al.  Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation. , 2012, Journal of pharmaceutical sciences.

[116]  Dongmei Cun,et al.  Effect of Crystal Size on the In Vitro Dissolution and Oral Absorption of Nitrendipine in Rats , 2010, Pharmaceutical Research.

[117]  Shigeo Kojima,et al.  Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. , 2004, Journal of pharmaceutical sciences.

[118]  Gert Fricker,et al.  The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility , 2012, International journal of nanomedicine.

[119]  Gareth R. Williams,et al.  Polymer-based nanoparticulate solid dispersions prepared by a modified electrospraying process , 2011 .

[120]  Lokesh Kumar,et al.  Preparation and characterization of salt forms of enalapril. , 2008, Pharmaceutical development and technology.

[121]  A. Healy,et al.  Preparation and characterisation of novel chlorothiazide potassium solid-state salt forms: Intermolecular self assembly suprastructures. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[122]  J. Breitkreutz,et al.  Improved group contribution parameter set for the application of solubility parameters to melt extrusion. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[123]  Gautam R. Desiraju,et al.  Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .

[124]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[125]  E. Ferreira,et al.  Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug. , 2003, Bioorganic & medicinal chemistry.

[126]  Abolghasem Jouyban,et al.  Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[127]  J. Schellens,et al.  Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[128]  T. Rades,et al.  Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[129]  Jan P Möschwitzer,et al.  Drug nanocrystals in the commercial pharmaceutical development process. , 2013, International journal of pharmaceutics.

[130]  Jianjun Zhang,et al.  Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals. , 2012, International journal of pharmaceutics.

[131]  P Timmins,et al.  Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs , 2012, Drug development and industrial pharmacy.

[132]  James Mack,et al.  Mechanochemistry: opportunities for new and cleaner synthesis. , 2012, Chemical Society reviews.

[133]  Emmanuel Scheubel,et al.  Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid assessment of solid dispersion systems. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[134]  Neera Singh,et al.  Sorption of metolachlor and atrazine in fly ash amended soils: Comparison of optimized isotherm models , 2012, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[135]  Jonathan Brown,et al.  Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. , 2009, International journal of pharmaceutics.

[136]  I. Ghosh,et al.  Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[137]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[138]  S. Yalkowsky,et al.  Solubilization of poorly soluble compounds using 2-pyrrolidone. , 2007, International journal of pharmaceutics.

[139]  Rainer H Müller,et al.  Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.